Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 2, 2013, Pages 511-521

  Friend, Danielle M ^a   Son, Jong H ^b   Keefe, Kristen A ^a,b   Fricks Gleason, Ashley N ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; METHAMPHETAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; VESICULAR MONOAMINE TRANSPORTER 2;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE DEPLETION; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME SYNTHESIS; MALE; NEUROTOXICITY; NITRATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRIATE CORTEX;

ANIMALS; CORPUS STRIATUM; DOPAMINE; ENZYME INDUCTION; IN SITU HYBRIDIZATION; INTERNEURONS; ISOENZYMES; MALE; METHAMPHETAMINE; NEUROTOXICITY SYNDROMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84872722701     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.199745     Document Type: Article

References (61)

1. Ali SF and Itzhak Y (1998) Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann N Y Acad Sci 844:122-130. (Pubitemid 28367801)
2. Ali SF, Newport GD, Holson RR, Slikker W, Jr., and Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-378.
3. Anderson KL and Itzhak Y (2006) Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse. Ann N Y Acad Sci 1074:225-233. (Pubitemid 44532826)
4. Blackshaw S, Eliasson MJ, Sawa A, Watkins CC, Krug D, Gupta A, Arai T, Ferrante RJ, and Snyder SH (2003) Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity. Neuroscience 119:979-990. (Pubitemid 36776448)
5. Bowyer JF, Clausing P, Gough B, Slikker W, Jr., and Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62-70.
6. Bredt DS and Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030-9033. (Pubitemid 20010361)
7. Callaghan RC, Cunningham JK, Sykes J, and Kish SJ (2012) Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 120: 35-40.
8. Callahan BT and Ricaurte GA (1998) Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity. Neuroreport 9:2691-2695. (Pubitemid 28435146)
9. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, and Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797-7801. (Pubitemid 21915241)
10. Deng X and Cadet JL (1999) Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res 851:254-257. (Pubitemid 30038153)
11. Di Monte DA, Royland JE, Jakowec MW, and Langston JW (1996) Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67:2443-2450. (Pubitemid 26392515)
12. Dinerman JL, Dawson TM, Schell MJ, Snowman A, and Snyder SH (1994) Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 91:4214-42178.
13. Doyle CA and Slater P (1997) Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience 76:387-395. (Pubitemid 27008470)
14. Garthwaite J, Charles SL, and Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-3878.
15. Gibson CL, Coughlan TC, and Murphy SP (2005) Glial nitric oxide and ischemia. Glia 50:417-426. (Pubitemid 40780845)
16. Gross NB, Duncker PC, and Marshall JF (2011) Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity. Synapse 65:1144-1155.
17. Guilarte TR, Nihei MK, McGlothan JL, and Howard AS (2003) Methamphetamineinduced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122:499-513. (Pubitemid 37410176)
18. Hanson JE, Birdsall E, Seferian KS, Crosby MA, Keefe KA, Gibb JW, Hanson GR, and Fleckenstein AE (2009) Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment. Eur J Pharmacol 607:68-73.
19. Hope BT, Michael GJ, Knigge KM, and Vincent SR (1991) Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88:2811-2814. (Pubitemid 21916509)
20. Hoque KE, Indorkar RP, Sammut S, and West AR (2010) Impact of dopamineglutamate interactions on striatal neuronal nitric oxide synthase activity. Psychopharmacology (Berl) 207:571-581.
21. Horner KA, Westwood SC, Hanson GR, and Keefe KA (2006) Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNAexpressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J Pharmacol Exp Ther 319:414-421. (Pubitemid 44455149)
22. Imam SZ, Crow JP, Newport GD, Islam F, Slikker W, Jr., and Ali SF (1999) Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res 837: 15-21. (Pubitemid 29369212)
23. Imam SZ, Islam F, Itzhak Y, Slikker W, Jr., and Ali SF (2000) Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage. Ann N Y Acad Sci 914:157-171.
24. Inoue H, Arai I, Shibata S, and Watanabe S (1996) NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine- induced behavioral sensitization and enhancement of striatal dopamine release. J Pharmacol Exp Ther 277:1424-1430.
25. Itzhak Y and Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773. (Pubitemid 26314238)
26. Itzhak Y, Anderson KL, and Ali SF (2004) Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity. Ann N Y Acad Sci 1025:119-1278.
27. Itzhak Y, Gandia C, Huang PL, and Ali SF (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284:1040-1047. (Pubitemid 28130833)
28. Itzhak Y, Martin JL, and Ail SF (2000a) nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. Neuroreport 11:2943-2946.
29. Itzhak Y, Martin JL, and Ali SF (1999) Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse 34:305-312. (Pubitemid 29523136)
30. Itzhak Y, Martin JL, and Ali SF (2000b) Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization. Ann N Y Acad Sci 914:104-111.
31. Iwahashi T, Inoue A, Koh CS, Shin TK, and Kim BS (1999) Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Cell Immunol 194: 186-193. (Pubitemid 29340170)
32. Kawaguchi Y, Wilson CJ, Augood SJ, and Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18: 527-535.
33. Keefe KA and Gerfen CR (1996) D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J Comp Neurol 367:165-176. (Pubitemid 26107109)
34. Kogan FJ, Nichols WK, and Gibb JW (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363-371.
35. LaVoie MJ, Card JP, and Hastings TG (2004) Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol 187:47-57. (Pubitemid 38470011)
36. Le Moine C, Normand E, and Bloch B (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 88:4205-4209. (Pubitemid 21914508)
37. Mark KA, Soghomonian JJ, and Yamamoto BK (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 24:11449-11456. (Pubitemid 39658280)
38. Maxwell JC (2005) Emerging research on methamphetamine. Curr Opin Psychiatry 18:235-242. (Pubitemid 40586105)
39. Morris BJ, Simpson CS, Mundell S, Maceachern K, Johnston HM, and Nolan AM (1997) Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology 36:1589-1599. (Pubitemid 28085919)
40. Nash JF and Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
41. O'Dell SJ, Weihmuller FB, and Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256-260.
42. O'Dell SJ, Weihmuller FB, and Marshall JF (1993) Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem 60:1792-1799. (Pubitemid 23127585)
43. Oleszak EL, Katsetos CD, Kuzmak J, and Varadhachary A (1997) Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection. J Virol 71: 3228-3235. (Pubitemid 27119970)
44. Park DJ and West AR (2009) Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions. J Neurochem 111:1457-1465.
45. Pastuzyn ED, Chapman DE, Wilcox KS, and Keefe KA (2012) Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine- induced neurotoxicity. Neuropsychopharmacology 37:885-895.
46. Radi R, Beckman JS, Bush KM, and Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:481-487.
47. Rushlow W, Flumerfelt BA, and Naus CC (1995) Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat. J Comp Neurol 351:499-5078.
48. Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, and West AR (2006) Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology 31:493-505. (Pubitemid 43276965)
49. Taraska T and Finnegan KT (1997) Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 280:941-947. (Pubitemid 27171359)
50. Thomas DM and Kuhn DM (2005) Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 92:790-797. (Pubitemid 40229550)
51. Uhl GR and Sasek CA (1986) Somatostatin mRNA: regional variation in hybridization densities in individual neurons. J Neurosci 6:3258-3264. (Pubitemid 17186051)
52. Vaid RR, Yee BK, Rawlins JN, and Totterdell S (1996) NADPH-diaphorase reactive pyramidal neurons in Ammon's horn and the subiculum of the rat hippocampal formation. Brain Res 733:31-40. (Pubitemid 26300954)
53. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, and Ding YS, et al. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382. (Pubitemid 32205193)
54. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, and Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151-160. (Pubitemid 10159505)
55. Wang J and Angulo JA (2011) Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice. Brain Res 1369:131-139.
56. Wang J, Xu W, Ali SF, and Angulo JA (2008) Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure. Ann N Y Acad Sci 1139:164-171.
57. West AR and Galloway MP (1997) Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptordependent mechanisms. Neuropharmacology 36:1571-1581. (Pubitemid 28085917)
58. West AR, Galloway MP, and Grace AA (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44:227-245. (Pubitemid 34496647)
59. Zhu J, Xu W, Wang J, Ali SF, and Angulo JA (2009) The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J Neurochem 111:656-6678.
60. Zhu JP, Xu W, and Angulo JA (2006) Distinct mechanisms mediating methamphetamine- induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice. Ann N Y Acad Sci 1074:135-1478.
61. Zhu XZ and Luo LG (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932-935.